Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination?
about
Antibiotic-free selection in biotherapeutics: now and foreverThe expression of heterologous MAM-7 in Lactobacillus rhamnosus reduces its intrinsic capacity to inhibit colonization of pathogen Vibrio parahaemolyticus in vitro.Heterologous expression of a recombinant lactobacillal β-galactosidase in Lactobacillus plantarum: effect of different parameters on the sakacin P-based expression systemLactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.PilVax - a novel peptide delivery platform for the development of mucosal vaccines.Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.
P2860
Recombinant lactic acid bacteria as delivery vectors of heterologous antigens: the future of vaccination?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Recombinant lactic acid bacter ...... ns: the future of vaccination?
@en
type
label
Recombinant lactic acid bacter ...... ns: the future of vaccination?
@en
prefLabel
Recombinant lactic acid bacter ...... ns: the future of vaccination?
@en
P2860
P356
P1433
P1476
Recombinant lactic acid bacter ...... ns: the future of vaccination?
@en
P2093
A Trombert
P2860
P304
P356
10.3920/BM2014.0068
P577
2015-01-01T00:00:00Z